| Literature DB >> 27563067 |
Sandra Paschkowsky1, Mehdi Hamzé1, Felix Oestereich2, Lisa Marie Munter3.
Abstract
The amyloid precursor protein (APP) is an ubiquitously expressed cell surface protein and a key molecule in the etiology of Alzheimer disease. Amyloidogenic processing of APP through secretases leads to the generation of toxic amyloid β (Aβ) peptides, which are regarded as the molecular cause of the disease. We report here an alternative processing pathway of APP through the mammalian intramembrane rhomboid protease RHBDL4. RHBDL4 efficiently cleaves APP inside the cell, thus bypassing APP from amyloidogenic processing, leading to reduced Aβ levels. RHBDL4 cleaves APP multiple times in the ectodomain, resulting in several N- and C-terminal fragments that are not further degraded by classical APP secretases. Knockdown of endogenous RHBDL4 results in decreased levels of C-terminal fragments derived from endogenous APP. Similarly, we found the APP family members APLP1 and APLP2 to be substrates of RHBDL4. We conclude that RHBDL4-mediated APP processing provides insight into APP and rhomboid physiology and qualifies for further investigations to elaborate its impact on Alzheimer disease pathology.Entities:
Keywords: APLP1; APLP2; APP fragments; amyloid precursor protein (APP); amyloid β (Aβ); endoplasmic reticulum (ER); lysosome; rhomboid protease
Mesh:
Substances:
Year: 2016 PMID: 27563067 PMCID: PMC5063975 DOI: 10.1074/jbc.M116.753582
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157